Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announc

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Present Topline Data from Pha

Amylyx Pharma (NASDAQ:AMLX) held its second-quarter earnings conference call on Thursday. Below is t

Amylyx Pharmaceuticals (NASDAQ: AMLX - Get Free Report) and Dyadic International (NASDAQ: DYAI - Get

Amylyx Pharmaceuticals NASDAQ: AMLX said its Phase III trial of avexitide in post-bariatric hypoglyc

Bond yields, oil prices, and inflation rhetoric have teamed up to make it tough for investors headin

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Morgan Stanley 24th Annual Global Healthcare Confere

Vanguard's broader healthcare portfolio charges less and yields more, but State Street's pharma-focu

FHLC captures the whole healthcare opportunity at rock-bottom cost. XPH narrows the bet to pharmaceu

Amylyx Pharmaceuticals raised $500 million to strengthen its balance sheet. A potential 2027 drug la

BlackRock Inc. bought a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) in the

BlackRock Inc. bought a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) in the

Certain stocks are such poor bets that they are likely to lose ground even in bull markets.

Guggenheim analyst Seamus Fernandez maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and

Almitas Capital LLC acquired a new stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) in

Deutsche Bank AG bought a new stake in Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) in the undefined

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a lo

Analysts also raised their price targets on the company. On top of that, it launched a new round of

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” o

Mizuho analyst Graig Suvannavejh maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform

Amylyx surges after avexitide cuts hypoglycemic events 55% in phase III LUCIDITY study, paving the w

Guggenheim analyst Seamus Fernandez maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and

Baird analyst Joel Beatty maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform and ra

PFSA, BIDU, AMLX, CAST, KLAR were among the stocks seen trending on Tuesday, Aug. 18, 2026.

Amylyx is developing a GLP-1 treatment for people with chronic low blood sugar. The experimental the

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” o

Amylyx Pharmaceuticals (AMLX) shares exploded to the upside on August 18th after the company reporte

HC Wainwright & Co. analyst Andrew S. Fein maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) wit

Gainers AIxCrypto Hldgs (NASDAQ:AIXC) stock increased by 132.0% to $1.65 during Tuesday's regul

US stocks fell in midday trading, with S&P 500 down 0.5% and Dow dropping 0.17%. Health care sha

US stocks down, Nasdaq falls 300+ points. Duos Tech shares rise on better Q2 results. Many other bi

Amylyx Pharmaceuticals posts positive Phase 3 avexitide data for post-bariatric hypoglycemia. The co

Gainers Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday'

XOS: 140% | Xos shares are trading higher after the company announced that it has been awarded a pro

LUCIDITY met FDA-agreed-upon primary endpoint; avexitide demonstrated a 55% reduction in the composi

Flexsteel Industries Inc (FLXS) reported better-than-expected Q4 results, with shares jumping 9% in

Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after

Amylyx Pharmaceuticals shares are trading higher Monday after the company scheduled a Phase 3 trial

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") will announce

Mizuho analyst Graig Suvannavejh maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform

Amylyx Pharma (NASDAQ:AMLX) reported quarterly losses of $(0.39) per share which missed the analyst

Citigroup analyst Geoff Meacham maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and rai

US stock futures higher with Dow up 200 pts, Beyond Meat shares drop after downbeat results; ORIC, R

Top Wall Street analysts changed outlook on top names. Check out analyst ratings page for all change